focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

5 Feb 2018 17:07

RNS Number : 9715D
Ergomed plc
05 February 2018
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Ergomed Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Slater Investments Ltd

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

06th February 2018

6. Date on which issuer notified:

05th February 2018

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BN7ZCY67

4,129,000

9.67%

161,000

161,000

4,308,000

0.36%

9.64%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,469,000

10.00%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Ralph Baber

15. Contact telephone number:

+ 44 20 7220 9460

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLTAMRTMBMMBAP
Date   Source Headline
1st Jul 20197:00 amRNSTotal Voting Rights & Block Listing Return
25th Jun 20197:00 amRNSDirector/PDMR Shareholding
19th Jun 20197:00 amRNSShare Options
18th Jun 20193:04 pmRNSBoard Appointment
18th Jun 20192:59 pmRNSResult of AGM
13th Jun 20197:00 amRNSDirector/PDMR Shareholding
10th Jun 20197:00 amRNSPDMR Dealing
4th Jun 20197:00 amRNSAppointment of CFO
3rd Jun 20197:00 amRNSTotal Voting Rights
20th May 20196:30 pmRNSHolding(s) in Company
17th May 20197:00 amRNSNotice of AGM and Annual Report
16th May 20197:01 amRNSHolding(s) in Company
16th May 20197:00 amRNSTrading Update
9th May 201911:15 amRNSHoldings in Company
3rd May 20191:08 pmRNSHolding(s) in Company
23rd Apr 20197:00 amRNSErgomed's PrimeVigilance receives Queen's Award
12th Apr 20197:00 amRNSEarn-Out Shares and PDMR Dealing
10th Apr 20197:00 amRNSPreliminary Results
2nd Apr 20197:00 amRNSNotice of Preliminary Results
1st Apr 20197:00 amRNSRoy Ovel appointed as Chief Commercial Officer
1st Apr 20197:00 amRNSTotal Voting Rights
11th Mar 20191:52 pmRNSChristopher Collins
1st Mar 20197:00 amRNSTotal Voting Rights
13th Feb 20197:00 amRNSProposed Board and Management Changes
1st Feb 201911:31 amRNSExercise of Options & Issue of Equity
31st Jan 20197:00 amRNSErgomed 2018 Trading Update
23rd Jan 20197:00 amRNSBoard and Management Changes
21st Jan 20197:00 amRNSHoldings in Company
4th Jan 201910:34 amRNSDirectors' Dealing
2nd Jan 20197:00 amRNSBlock Listing Six Monthly Return
27th Nov 20181:50 pmRNSHoldings in Company
5th Nov 20182:03 pmRNSHoldings in Company
1st Nov 20182:44 pmRNSErgomed issue of shares
2nd Oct 20182:47 pmRNSBoard Changes
19th Sep 20187:00 amRNSInterim Results
14th Sep 20187:00 amRNSNotice of Interim Results
16th Aug 20184:36 pmRNSHoldings in Company
16th Jul 20185:31 pmRNSChange of auditor
4th Jul 201811:11 amRNSIssue of shares
3rd Jul 20187:00 amRNSAward of share options
2nd Jul 20187:00 amRNSBoard appointment
28th Jun 20187:00 amRNSTrading Update
27th Jun 201811:52 amRNSBlock listing application
21st Jun 20189:11 amRNSExercise of options
15th Jun 20183:14 pmRNSChange of Registered Office
12th Jun 20183:55 pmRNSResults of 2018 Annual General Meeting
25th May 20187:00 amRNSKey hire in pharmacoepidemiology services
24th May 20184:00 pmRNSHolding(s) in Company
21st May 20183:35 pmRNSNotice of AGM
2nd May 20187:00 amRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.